Pharma & Healthcare
Global Prophylactic Gamma Globulin Market Research Report 2025
- May 26, 25
- ID: 273272
- Pages: 107
- Figures: 104
- Views: 15
The global market for Prophylactic Gamma Globulin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The gamma globulin fraction of pooled normal human sera has a wide range of usefulness in the prophylaxis of many infectious diseases. Hyperimmune human globulin preparations are effective against certain other illnesses in which globulins pooled from normal sera contain insufficient antibody.
North American market for Prophylactic Gamma Globulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prophylactic Gamma Globulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Prophylactic Gamma Globulin include Baxter, Grifols, Octapharma, Biotest, Kedrion Biopharma, Takeda, ADMA Biologics, BPL, LFB Group, Hualan Biological, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prophylactic Gamma Globulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prophylactic Gamma Globulin.
The Prophylactic Gamma Globulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prophylactic Gamma Globulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prophylactic Gamma Globulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter
Grifols
Octapharma
Biotest
Kedrion Biopharma
Takeda
ADMA Biologics
BPL
LFB Group
Hualan Biological
Beijing Tiantan Biological
Beijing Bohui Innovation Biotechnology
Pacific Shuanglin Bio-pharmacy
Shenzhen Weiguang Biological
CBPO
CNBG
Shanghai RAAS
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prophylactic Gamma Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prophylactic Gamma Globulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The gamma globulin fraction of pooled normal human sera has a wide range of usefulness in the prophylaxis of many infectious diseases. Hyperimmune human globulin preparations are effective against certain other illnesses in which globulins pooled from normal sera contain insufficient antibody.
North American market for Prophylactic Gamma Globulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prophylactic Gamma Globulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Prophylactic Gamma Globulin include Baxter, Grifols, Octapharma, Biotest, Kedrion Biopharma, Takeda, ADMA Biologics, BPL, LFB Group, Hualan Biological, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prophylactic Gamma Globulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prophylactic Gamma Globulin.
The Prophylactic Gamma Globulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prophylactic Gamma Globulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prophylactic Gamma Globulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter
Grifols
Octapharma
Biotest
Kedrion Biopharma
Takeda
ADMA Biologics
BPL
LFB Group
Hualan Biological
Beijing Tiantan Biological
Beijing Bohui Innovation Biotechnology
Pacific Shuanglin Bio-pharmacy
Shenzhen Weiguang Biological
CBPO
CNBG
Shanghai RAAS
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prophylactic Gamma Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prophylactic Gamma Globulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Prophylactic Gamma Globulin Market Overview
1.1 Product Definition
1.2 Prophylactic Gamma Globulin by Type
1.2.1 Global Prophylactic Gamma Globulin Market Value Comparison by Type (2024 VS 2031)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Prophylactic Gamma Globulin by Application
1.3.1 Global Prophylactic Gamma Globulin Market Value by Application (2024 VS 2031)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Prophylactic Gamma Globulin Market Size Estimates and Forecasts
1.4.1 Global Prophylactic Gamma Globulin Revenue 2020-2031
1.4.2 Global Prophylactic Gamma Globulin Sales 2020-2031
1.4.3 Global Prophylactic Gamma Globulin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prophylactic Gamma Globulin Market Competition by Manufacturers
2.1 Global Prophylactic Gamma Globulin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prophylactic Gamma Globulin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prophylactic Gamma Globulin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prophylactic Gamma Globulin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prophylactic Gamma Globulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prophylactic Gamma Globulin, Product Type & Application
2.7 Global Key Manufacturers of Prophylactic Gamma Globulin, Date of Enter into This Industry
2.8 Global Prophylactic Gamma Globulin Market Competitive Situation and Trends
2.8.1 Global Prophylactic Gamma Globulin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prophylactic Gamma Globulin Players Market Share by Revenue
2.8.3 Global Prophylactic Gamma Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prophylactic Gamma Globulin Market Scenario by Region
3.1 Global Prophylactic Gamma Globulin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prophylactic Gamma Globulin Sales by Region: 2020-2031
3.2.1 Global Prophylactic Gamma Globulin Sales by Region: 2020-2025
3.2.2 Global Prophylactic Gamma Globulin Sales by Region: 2026-2031
3.3 Global Prophylactic Gamma Globulin Revenue by Region: 2020-2031
3.3.1 Global Prophylactic Gamma Globulin Revenue by Region: 2020-2025
3.3.2 Global Prophylactic Gamma Globulin Revenue by Region: 2026-2031
3.4 North America Prophylactic Gamma Globulin Market Facts & Figures by Country
3.4.1 North America Prophylactic Gamma Globulin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prophylactic Gamma Globulin Sales by Country (2020-2031)
3.4.3 North America Prophylactic Gamma Globulin Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prophylactic Gamma Globulin Market Facts & Figures by Country
3.5.1 Europe Prophylactic Gamma Globulin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prophylactic Gamma Globulin Sales by Country (2020-2031)
3.5.3 Europe Prophylactic Gamma Globulin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prophylactic Gamma Globulin Market Facts & Figures by Region
3.6.1 Asia Pacific Prophylactic Gamma Globulin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prophylactic Gamma Globulin Sales by Region (2020-2031)
3.6.3 Asia Pacific Prophylactic Gamma Globulin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prophylactic Gamma Globulin Market Facts & Figures by Country
3.7.1 Latin America Prophylactic Gamma Globulin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prophylactic Gamma Globulin Sales by Country (2020-2031)
3.7.3 Latin America Prophylactic Gamma Globulin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prophylactic Gamma Globulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Prophylactic Gamma Globulin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prophylactic Gamma Globulin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prophylactic Gamma Globulin Sales by Type (2020-2031)
4.1.1 Global Prophylactic Gamma Globulin Sales by Type (2020-2025)
4.1.2 Global Prophylactic Gamma Globulin Sales by Type (2026-2031)
4.1.3 Global Prophylactic Gamma Globulin Sales Market Share by Type (2020-2031)
4.2 Global Prophylactic Gamma Globulin Revenue by Type (2020-2031)
4.2.1 Global Prophylactic Gamma Globulin Revenue by Type (2020-2025)
4.2.2 Global Prophylactic Gamma Globulin Revenue by Type (2026-2031)
4.2.3 Global Prophylactic Gamma Globulin Revenue Market Share by Type (2020-2031)
4.3 Global Prophylactic Gamma Globulin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prophylactic Gamma Globulin Sales by Application (2020-2031)
5.1.1 Global Prophylactic Gamma Globulin Sales by Application (2020-2025)
5.1.2 Global Prophylactic Gamma Globulin Sales by Application (2026-2031)
5.1.3 Global Prophylactic Gamma Globulin Sales Market Share by Application (2020-2031)
5.2 Global Prophylactic Gamma Globulin Revenue by Application (2020-2031)
5.2.1 Global Prophylactic Gamma Globulin Revenue by Application (2020-2025)
5.2.2 Global Prophylactic Gamma Globulin Revenue by Application (2026-2031)
5.2.3 Global Prophylactic Gamma Globulin Revenue Market Share by Application (2020-2031)
5.3 Global Prophylactic Gamma Globulin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Prophylactic Gamma Globulin Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Prophylactic Gamma Globulin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Octapharma
6.3.1 Octapharma Company Information
6.3.2 Octapharma Description and Business Overview
6.3.3 Octapharma Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Octapharma Prophylactic Gamma Globulin Product Portfolio
6.3.5 Octapharma Recent Developments/Updates
6.4 Biotest
6.4.1 Biotest Company Information
6.4.2 Biotest Description and Business Overview
6.4.3 Biotest Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biotest Prophylactic Gamma Globulin Product Portfolio
6.4.5 Biotest Recent Developments/Updates
6.5 Kedrion Biopharma
6.5.1 Kedrion Biopharma Company Information
6.5.2 Kedrion Biopharma Description and Business Overview
6.5.3 Kedrion Biopharma Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Kedrion Biopharma Prophylactic Gamma Globulin Product Portfolio
6.5.5 Kedrion Biopharma Recent Developments/Updates
6.6 Takeda
6.6.1 Takeda Company Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Takeda Prophylactic Gamma Globulin Product Portfolio
6.6.5 Takeda Recent Developments/Updates
6.7 ADMA Biologics
6.7.1 ADMA Biologics Company Information
6.7.2 ADMA Biologics Description and Business Overview
6.7.3 ADMA Biologics Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ADMA Biologics Prophylactic Gamma Globulin Product Portfolio
6.7.5 ADMA Biologics Recent Developments/Updates
6.8 BPL
6.8.1 BPL Company Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BPL Prophylactic Gamma Globulin Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 LFB Group
6.9.1 LFB Group Company Information
6.9.2 LFB Group Description and Business Overview
6.9.3 LFB Group Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 LFB Group Prophylactic Gamma Globulin Product Portfolio
6.9.5 LFB Group Recent Developments/Updates
6.10 Hualan Biological
6.10.1 Hualan Biological Company Information
6.10.2 Hualan Biological Description and Business Overview
6.10.3 Hualan Biological Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hualan Biological Prophylactic Gamma Globulin Product Portfolio
6.10.5 Hualan Biological Recent Developments/Updates
6.11 Beijing Tiantan Biological
6.11.1 Beijing Tiantan Biological Company Information
6.11.2 Beijing Tiantan Biological Description and Business Overview
6.11.3 Beijing Tiantan Biological Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Beijing Tiantan Biological Prophylactic Gamma Globulin Product Portfolio
6.11.5 Beijing Tiantan Biological Recent Developments/Updates
6.12 Beijing Bohui Innovation Biotechnology
6.12.1 Beijing Bohui Innovation Biotechnology Company Information
6.12.2 Beijing Bohui Innovation Biotechnology Description and Business Overview
6.12.3 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product Portfolio
6.12.5 Beijing Bohui Innovation Biotechnology Recent Developments/Updates
6.13 Pacific Shuanglin Bio-pharmacy
6.13.1 Pacific Shuanglin Bio-pharmacy Company Information
6.13.2 Pacific Shuanglin Bio-pharmacy Description and Business Overview
6.13.3 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product Portfolio
6.13.5 Pacific Shuanglin Bio-pharmacy Recent Developments/Updates
6.14 Shenzhen Weiguang Biological
6.14.1 Shenzhen Weiguang Biological Company Information
6.14.2 Shenzhen Weiguang Biological Description and Business Overview
6.14.3 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product Portfolio
6.14.5 Shenzhen Weiguang Biological Recent Developments/Updates
6.15 CBPO
6.15.1 CBPO Company Information
6.15.2 CBPO Description and Business Overview
6.15.3 CBPO Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 CBPO Prophylactic Gamma Globulin Product Portfolio
6.15.5 CBPO Recent Developments/Updates
6.16 CNBG
6.16.1 CNBG Company Information
6.16.2 CNBG Description and Business Overview
6.16.3 CNBG Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 CNBG Prophylactic Gamma Globulin Product Portfolio
6.16.5 CNBG Recent Developments/Updates
6.17 Shanghai RAAS
6.17.1 Shanghai RAAS Company Information
6.17.2 Shanghai RAAS Description and Business Overview
6.17.3 Shanghai RAAS Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Shanghai RAAS Prophylactic Gamma Globulin Product Portfolio
6.17.5 Shanghai RAAS Recent Developments/Updates
6.18 Sichuan Yuanda Shuyang
6.18.1 Sichuan Yuanda Shuyang Company Information
6.18.2 Sichuan Yuanda Shuyang Description and Business Overview
6.18.3 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product Portfolio
6.18.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prophylactic Gamma Globulin Industry Chain Analysis
7.2 Prophylactic Gamma Globulin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prophylactic Gamma Globulin Production Mode & Process Analysis
7.4 Prophylactic Gamma Globulin Sales and Marketing
7.4.1 Prophylactic Gamma Globulin Sales Channels
7.4.2 Prophylactic Gamma Globulin Distributors
7.5 Prophylactic Gamma Globulin Customer Analysis
8 Prophylactic Gamma Globulin Market Dynamics
8.1 Prophylactic Gamma Globulin Industry Trends
8.2 Prophylactic Gamma Globulin Market Drivers
8.3 Prophylactic Gamma Globulin Market Challenges
8.4 Prophylactic Gamma Globulin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Prophylactic Gamma Globulin by Type
1.2.1 Global Prophylactic Gamma Globulin Market Value Comparison by Type (2024 VS 2031)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Prophylactic Gamma Globulin by Application
1.3.1 Global Prophylactic Gamma Globulin Market Value by Application (2024 VS 2031)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Prophylactic Gamma Globulin Market Size Estimates and Forecasts
1.4.1 Global Prophylactic Gamma Globulin Revenue 2020-2031
1.4.2 Global Prophylactic Gamma Globulin Sales 2020-2031
1.4.3 Global Prophylactic Gamma Globulin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prophylactic Gamma Globulin Market Competition by Manufacturers
2.1 Global Prophylactic Gamma Globulin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prophylactic Gamma Globulin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prophylactic Gamma Globulin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prophylactic Gamma Globulin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prophylactic Gamma Globulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prophylactic Gamma Globulin, Product Type & Application
2.7 Global Key Manufacturers of Prophylactic Gamma Globulin, Date of Enter into This Industry
2.8 Global Prophylactic Gamma Globulin Market Competitive Situation and Trends
2.8.1 Global Prophylactic Gamma Globulin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prophylactic Gamma Globulin Players Market Share by Revenue
2.8.3 Global Prophylactic Gamma Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prophylactic Gamma Globulin Market Scenario by Region
3.1 Global Prophylactic Gamma Globulin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prophylactic Gamma Globulin Sales by Region: 2020-2031
3.2.1 Global Prophylactic Gamma Globulin Sales by Region: 2020-2025
3.2.2 Global Prophylactic Gamma Globulin Sales by Region: 2026-2031
3.3 Global Prophylactic Gamma Globulin Revenue by Region: 2020-2031
3.3.1 Global Prophylactic Gamma Globulin Revenue by Region: 2020-2025
3.3.2 Global Prophylactic Gamma Globulin Revenue by Region: 2026-2031
3.4 North America Prophylactic Gamma Globulin Market Facts & Figures by Country
3.4.1 North America Prophylactic Gamma Globulin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prophylactic Gamma Globulin Sales by Country (2020-2031)
3.4.3 North America Prophylactic Gamma Globulin Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prophylactic Gamma Globulin Market Facts & Figures by Country
3.5.1 Europe Prophylactic Gamma Globulin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prophylactic Gamma Globulin Sales by Country (2020-2031)
3.5.3 Europe Prophylactic Gamma Globulin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prophylactic Gamma Globulin Market Facts & Figures by Region
3.6.1 Asia Pacific Prophylactic Gamma Globulin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prophylactic Gamma Globulin Sales by Region (2020-2031)
3.6.3 Asia Pacific Prophylactic Gamma Globulin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prophylactic Gamma Globulin Market Facts & Figures by Country
3.7.1 Latin America Prophylactic Gamma Globulin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prophylactic Gamma Globulin Sales by Country (2020-2031)
3.7.3 Latin America Prophylactic Gamma Globulin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prophylactic Gamma Globulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Prophylactic Gamma Globulin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prophylactic Gamma Globulin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prophylactic Gamma Globulin Sales by Type (2020-2031)
4.1.1 Global Prophylactic Gamma Globulin Sales by Type (2020-2025)
4.1.2 Global Prophylactic Gamma Globulin Sales by Type (2026-2031)
4.1.3 Global Prophylactic Gamma Globulin Sales Market Share by Type (2020-2031)
4.2 Global Prophylactic Gamma Globulin Revenue by Type (2020-2031)
4.2.1 Global Prophylactic Gamma Globulin Revenue by Type (2020-2025)
4.2.2 Global Prophylactic Gamma Globulin Revenue by Type (2026-2031)
4.2.3 Global Prophylactic Gamma Globulin Revenue Market Share by Type (2020-2031)
4.3 Global Prophylactic Gamma Globulin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prophylactic Gamma Globulin Sales by Application (2020-2031)
5.1.1 Global Prophylactic Gamma Globulin Sales by Application (2020-2025)
5.1.2 Global Prophylactic Gamma Globulin Sales by Application (2026-2031)
5.1.3 Global Prophylactic Gamma Globulin Sales Market Share by Application (2020-2031)
5.2 Global Prophylactic Gamma Globulin Revenue by Application (2020-2031)
5.2.1 Global Prophylactic Gamma Globulin Revenue by Application (2020-2025)
5.2.2 Global Prophylactic Gamma Globulin Revenue by Application (2026-2031)
5.2.3 Global Prophylactic Gamma Globulin Revenue Market Share by Application (2020-2031)
5.3 Global Prophylactic Gamma Globulin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Prophylactic Gamma Globulin Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Prophylactic Gamma Globulin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Octapharma
6.3.1 Octapharma Company Information
6.3.2 Octapharma Description and Business Overview
6.3.3 Octapharma Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Octapharma Prophylactic Gamma Globulin Product Portfolio
6.3.5 Octapharma Recent Developments/Updates
6.4 Biotest
6.4.1 Biotest Company Information
6.4.2 Biotest Description and Business Overview
6.4.3 Biotest Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biotest Prophylactic Gamma Globulin Product Portfolio
6.4.5 Biotest Recent Developments/Updates
6.5 Kedrion Biopharma
6.5.1 Kedrion Biopharma Company Information
6.5.2 Kedrion Biopharma Description and Business Overview
6.5.3 Kedrion Biopharma Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Kedrion Biopharma Prophylactic Gamma Globulin Product Portfolio
6.5.5 Kedrion Biopharma Recent Developments/Updates
6.6 Takeda
6.6.1 Takeda Company Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Takeda Prophylactic Gamma Globulin Product Portfolio
6.6.5 Takeda Recent Developments/Updates
6.7 ADMA Biologics
6.7.1 ADMA Biologics Company Information
6.7.2 ADMA Biologics Description and Business Overview
6.7.3 ADMA Biologics Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ADMA Biologics Prophylactic Gamma Globulin Product Portfolio
6.7.5 ADMA Biologics Recent Developments/Updates
6.8 BPL
6.8.1 BPL Company Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BPL Prophylactic Gamma Globulin Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 LFB Group
6.9.1 LFB Group Company Information
6.9.2 LFB Group Description and Business Overview
6.9.3 LFB Group Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 LFB Group Prophylactic Gamma Globulin Product Portfolio
6.9.5 LFB Group Recent Developments/Updates
6.10 Hualan Biological
6.10.1 Hualan Biological Company Information
6.10.2 Hualan Biological Description and Business Overview
6.10.3 Hualan Biological Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hualan Biological Prophylactic Gamma Globulin Product Portfolio
6.10.5 Hualan Biological Recent Developments/Updates
6.11 Beijing Tiantan Biological
6.11.1 Beijing Tiantan Biological Company Information
6.11.2 Beijing Tiantan Biological Description and Business Overview
6.11.3 Beijing Tiantan Biological Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Beijing Tiantan Biological Prophylactic Gamma Globulin Product Portfolio
6.11.5 Beijing Tiantan Biological Recent Developments/Updates
6.12 Beijing Bohui Innovation Biotechnology
6.12.1 Beijing Bohui Innovation Biotechnology Company Information
6.12.2 Beijing Bohui Innovation Biotechnology Description and Business Overview
6.12.3 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product Portfolio
6.12.5 Beijing Bohui Innovation Biotechnology Recent Developments/Updates
6.13 Pacific Shuanglin Bio-pharmacy
6.13.1 Pacific Shuanglin Bio-pharmacy Company Information
6.13.2 Pacific Shuanglin Bio-pharmacy Description and Business Overview
6.13.3 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product Portfolio
6.13.5 Pacific Shuanglin Bio-pharmacy Recent Developments/Updates
6.14 Shenzhen Weiguang Biological
6.14.1 Shenzhen Weiguang Biological Company Information
6.14.2 Shenzhen Weiguang Biological Description and Business Overview
6.14.3 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product Portfolio
6.14.5 Shenzhen Weiguang Biological Recent Developments/Updates
6.15 CBPO
6.15.1 CBPO Company Information
6.15.2 CBPO Description and Business Overview
6.15.3 CBPO Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 CBPO Prophylactic Gamma Globulin Product Portfolio
6.15.5 CBPO Recent Developments/Updates
6.16 CNBG
6.16.1 CNBG Company Information
6.16.2 CNBG Description and Business Overview
6.16.3 CNBG Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 CNBG Prophylactic Gamma Globulin Product Portfolio
6.16.5 CNBG Recent Developments/Updates
6.17 Shanghai RAAS
6.17.1 Shanghai RAAS Company Information
6.17.2 Shanghai RAAS Description and Business Overview
6.17.3 Shanghai RAAS Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Shanghai RAAS Prophylactic Gamma Globulin Product Portfolio
6.17.5 Shanghai RAAS Recent Developments/Updates
6.18 Sichuan Yuanda Shuyang
6.18.1 Sichuan Yuanda Shuyang Company Information
6.18.2 Sichuan Yuanda Shuyang Description and Business Overview
6.18.3 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product Portfolio
6.18.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prophylactic Gamma Globulin Industry Chain Analysis
7.2 Prophylactic Gamma Globulin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prophylactic Gamma Globulin Production Mode & Process Analysis
7.4 Prophylactic Gamma Globulin Sales and Marketing
7.4.1 Prophylactic Gamma Globulin Sales Channels
7.4.2 Prophylactic Gamma Globulin Distributors
7.5 Prophylactic Gamma Globulin Customer Analysis
8 Prophylactic Gamma Globulin Market Dynamics
8.1 Prophylactic Gamma Globulin Industry Trends
8.2 Prophylactic Gamma Globulin Market Drivers
8.3 Prophylactic Gamma Globulin Market Challenges
8.4 Prophylactic Gamma Globulin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Prophylactic Gamma Globulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Prophylactic Gamma Globulin Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Prophylactic Gamma Globulin Market Competitive Situation by Manufacturers in 2024
Table 4. Global Prophylactic Gamma Globulin Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Prophylactic Gamma Globulin Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Prophylactic Gamma Globulin Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Prophylactic Gamma Globulin Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Prophylactic Gamma Globulin Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Prophylactic Gamma Globulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Prophylactic Gamma Globulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prophylactic Gamma Globulin, Product Type & Application
Table 12. Global Key Manufacturers of Prophylactic Gamma Globulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prophylactic Gamma Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prophylactic Gamma Globulin as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prophylactic Gamma Globulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Prophylactic Gamma Globulin Sales by Region (2020-2025) & (K Units)
Table 18. Global Prophylactic Gamma Globulin Sales Market Share by Region (2020-2025)
Table 19. Global Prophylactic Gamma Globulin Sales by Region (2026-2031) & (K Units)
Table 20. Global Prophylactic Gamma Globulin Sales Market Share by Region (2026-2031)
Table 21. Global Prophylactic Gamma Globulin Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Prophylactic Gamma Globulin Revenue Market Share by Region (2020-2025)
Table 23. Global Prophylactic Gamma Globulin Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Prophylactic Gamma Globulin Revenue Market Share by Region (2026-2031)
Table 25. North America Prophylactic Gamma Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Prophylactic Gamma Globulin Sales by Country (2020-2025) & (K Units)
Table 27. North America Prophylactic Gamma Globulin Sales by Country (2026-2031) & (K Units)
Table 28. North America Prophylactic Gamma Globulin Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Prophylactic Gamma Globulin Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Prophylactic Gamma Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Prophylactic Gamma Globulin Sales by Country (2020-2025) & (K Units)
Table 32. Europe Prophylactic Gamma Globulin Sales by Country (2026-2031) & (K Units)
Table 33. Europe Prophylactic Gamma Globulin Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Prophylactic Gamma Globulin Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Prophylactic Gamma Globulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Prophylactic Gamma Globulin Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Prophylactic Gamma Globulin Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Prophylactic Gamma Globulin Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Prophylactic Gamma Globulin Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Prophylactic Gamma Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Prophylactic Gamma Globulin Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Prophylactic Gamma Globulin Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Prophylactic Gamma Globulin Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Prophylactic Gamma Globulin Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Prophylactic Gamma Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Prophylactic Gamma Globulin Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Prophylactic Gamma Globulin Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Prophylactic Gamma Globulin Sales (K Units) by Type (2020-2025)
Table 51. Global Prophylactic Gamma Globulin Sales (K Units) by Type (2026-2031)
Table 52. Global Prophylactic Gamma Globulin Sales Market Share by Type (2020-2025)
Table 53. Global Prophylactic Gamma Globulin Sales Market Share by Type (2026-2031)
Table 54. Global Prophylactic Gamma Globulin Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Prophylactic Gamma Globulin Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2020-2025)
Table 57. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2026-2031)
Table 58. Global Prophylactic Gamma Globulin Price (US$/Unit) by Type (2020-2025)
Table 59. Global Prophylactic Gamma Globulin Price (US$/Unit) by Type (2026-2031)
Table 60. Global Prophylactic Gamma Globulin Sales (K Units) by Application (2020-2025)
Table 61. Global Prophylactic Gamma Globulin Sales (K Units) by Application (2026-2031)
Table 62. Global Prophylactic Gamma Globulin Sales Market Share by Application (2020-2025)
Table 63. Global Prophylactic Gamma Globulin Sales Market Share by Application (2026-2031)
Table 64. Global Prophylactic Gamma Globulin Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Prophylactic Gamma Globulin Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2020-2025)
Table 67. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2026-2031)
Table 68. Global Prophylactic Gamma Globulin Price (US$/Unit) by Application (2020-2025)
Table 69. Global Prophylactic Gamma Globulin Price (US$/Unit) by Application (2026-2031)
Table 70. Baxter Company Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Baxter Prophylactic Gamma Globulin Product
Table 74. Baxter Recent Developments/Updates
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Grifols Prophylactic Gamma Globulin Product
Table 79. Grifols Recent Developments/Updates
Table 80. Octapharma Company Information
Table 81. Octapharma Description and Business Overview
Table 82. Octapharma Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Octapharma Prophylactic Gamma Globulin Product
Table 84. Octapharma Recent Developments/Updates
Table 85. Biotest Company Information
Table 86. Biotest Description and Business Overview
Table 87. Biotest Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Biotest Prophylactic Gamma Globulin Product
Table 89. Biotest Recent Developments/Updates
Table 90. Kedrion Biopharma Company Information
Table 91. Kedrion Biopharma Description and Business Overview
Table 92. Kedrion Biopharma Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Kedrion Biopharma Prophylactic Gamma Globulin Product
Table 94. Kedrion Biopharma Recent Developments/Updates
Table 95. Takeda Company Information
Table 96. Takeda Description and Business Overview
Table 97. Takeda Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Takeda Prophylactic Gamma Globulin Product
Table 99. Takeda Recent Developments/Updates
Table 100. ADMA Biologics Company Information
Table 101. ADMA Biologics Description and Business Overview
Table 102. ADMA Biologics Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. ADMA Biologics Prophylactic Gamma Globulin Product
Table 104. ADMA Biologics Recent Developments/Updates
Table 105. BPL Company Information
Table 106. BPL Description and Business Overview
Table 107. BPL Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. BPL Prophylactic Gamma Globulin Product
Table 109. BPL Recent Developments/Updates
Table 110. LFB Group Company Information
Table 111. LFB Group Description and Business Overview
Table 112. LFB Group Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. LFB Group Prophylactic Gamma Globulin Product
Table 114. LFB Group Recent Developments/Updates
Table 115. Hualan Biological Company Information
Table 116. Hualan Biological Description and Business Overview
Table 117. Hualan Biological Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Hualan Biological Prophylactic Gamma Globulin Product
Table 119. Hualan Biological Recent Developments/Updates
Table 120. Beijing Tiantan Biological Company Information
Table 121. Beijing Tiantan Biological Description and Business Overview
Table 122. Beijing Tiantan Biological Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Beijing Tiantan Biological Prophylactic Gamma Globulin Product
Table 124. Beijing Tiantan Biological Recent Developments/Updates
Table 125. Beijing Bohui Innovation Biotechnology Company Information
Table 126. Beijing Bohui Innovation Biotechnology Description and Business Overview
Table 127. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product
Table 129. Beijing Bohui Innovation Biotechnology Recent Developments/Updates
Table 130. Pacific Shuanglin Bio-pharmacy Company Information
Table 131. Pacific Shuanglin Bio-pharmacy Description and Business Overview
Table 132. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product
Table 134. Pacific Shuanglin Bio-pharmacy Recent Developments/Updates
Table 135. Shenzhen Weiguang Biological Company Information
Table 136. Shenzhen Weiguang Biological Description and Business Overview
Table 137. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product
Table 139. Shenzhen Weiguang Biological Recent Developments/Updates
Table 140. CBPO Company Information
Table 141. CBPO Description and Business Overview
Table 142. CBPO Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. CBPO Prophylactic Gamma Globulin Product
Table 144. CBPO Recent Developments/Updates
Table 145. CNBG Company Information
Table 146. CNBG Description and Business Overview
Table 147. CNBG Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. CNBG Prophylactic Gamma Globulin Product
Table 149. CNBG Recent Developments/Updates
Table 150. Shanghai RAAS Company Information
Table 151. Shanghai RAAS Description and Business Overview
Table 152. Shanghai RAAS Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Shanghai RAAS Prophylactic Gamma Globulin Product
Table 154. Shanghai RAAS Recent Developments/Updates
Table 155. Sichuan Yuanda Shuyang Company Information
Table 156. Sichuan Yuanda Shuyang Description and Business Overview
Table 157. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product
Table 159. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Prophylactic Gamma Globulin Distributors List
Table 163. Prophylactic Gamma Globulin Customers List
Table 164. Prophylactic Gamma Globulin Market Trends
Table 165. Prophylactic Gamma Globulin Market Drivers
Table 166. Prophylactic Gamma Globulin Market Challenges
Table 167. Prophylactic Gamma Globulin Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Prophylactic Gamma Globulin
Figure 2. Global Prophylactic Gamma Globulin Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prophylactic Gamma Globulin Market Share by Type: 2024 & 2031
Figure 4. IVIg Liquid Product Picture
Figure 5. IVIg Powder Product Picture
Figure 6. Global Prophylactic Gamma Globulin Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Prophylactic Gamma Globulin Market Share by Application: 2024 & 2031
Figure 8. Immunodeficiency
Figure 9. Autoimmune Disease
Figure 10. Acute Infection
Figure 11. Global Prophylactic Gamma Globulin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Prophylactic Gamma Globulin Market Size (2020-2031) & (US$ Million)
Figure 13. Global Prophylactic Gamma Globulin Sales (2020-2031) & (K Units)
Figure 14. Global Prophylactic Gamma Globulin Average Price (US$/Unit) & (2020-2031)
Figure 15. Prophylactic Gamma Globulin Report Years Considered
Figure 16. Prophylactic Gamma Globulin Sales Share by Manufacturers in 2024
Figure 17. Global Prophylactic Gamma Globulin Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Prophylactic Gamma Globulin Players: Market Share by Revenue in Prophylactic Gamma Globulin in 2024
Figure 19. Prophylactic Gamma Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Prophylactic Gamma Globulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Prophylactic Gamma Globulin Sales Market Share by Country (2020-2031)
Figure 22. North America Prophylactic Gamma Globulin Revenue Market Share by Country (2020-2031)
Figure 23. United States Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Prophylactic Gamma Globulin Sales Market Share by Country (2020-2031)
Figure 26. Europe Prophylactic Gamma Globulin Revenue Market Share by Country (2020-2031)
Figure 27. Germany Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Prophylactic Gamma Globulin Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Prophylactic Gamma Globulin Revenue Market Share by Region (2020-2031)
Figure 34. China Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Prophylactic Gamma Globulin Sales Market Share by Country (2020-2031)
Figure 42. Latin America Prophylactic Gamma Globulin Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Prophylactic Gamma Globulin Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Prophylactic Gamma Globulin Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Prophylactic Gamma Globulin by Type (2020-2031)
Figure 52. Global Revenue Market Share of Prophylactic Gamma Globulin by Type (2020-2031)
Figure 53. Global Prophylactic Gamma Globulin Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Prophylactic Gamma Globulin by Application (2020-2031)
Figure 55. Global Revenue Market Share of Prophylactic Gamma Globulin by Application (2020-2031)
Figure 56. Global Prophylactic Gamma Globulin Price (US$/Unit) by Application (2020-2031)
Figure 57. Prophylactic Gamma Globulin Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Prophylactic Gamma Globulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Prophylactic Gamma Globulin Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Prophylactic Gamma Globulin Market Competitive Situation by Manufacturers in 2024
Table 4. Global Prophylactic Gamma Globulin Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Prophylactic Gamma Globulin Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Prophylactic Gamma Globulin Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Prophylactic Gamma Globulin Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Prophylactic Gamma Globulin Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Prophylactic Gamma Globulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Prophylactic Gamma Globulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prophylactic Gamma Globulin, Product Type & Application
Table 12. Global Key Manufacturers of Prophylactic Gamma Globulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prophylactic Gamma Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prophylactic Gamma Globulin as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prophylactic Gamma Globulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Prophylactic Gamma Globulin Sales by Region (2020-2025) & (K Units)
Table 18. Global Prophylactic Gamma Globulin Sales Market Share by Region (2020-2025)
Table 19. Global Prophylactic Gamma Globulin Sales by Region (2026-2031) & (K Units)
Table 20. Global Prophylactic Gamma Globulin Sales Market Share by Region (2026-2031)
Table 21. Global Prophylactic Gamma Globulin Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Prophylactic Gamma Globulin Revenue Market Share by Region (2020-2025)
Table 23. Global Prophylactic Gamma Globulin Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Prophylactic Gamma Globulin Revenue Market Share by Region (2026-2031)
Table 25. North America Prophylactic Gamma Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Prophylactic Gamma Globulin Sales by Country (2020-2025) & (K Units)
Table 27. North America Prophylactic Gamma Globulin Sales by Country (2026-2031) & (K Units)
Table 28. North America Prophylactic Gamma Globulin Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Prophylactic Gamma Globulin Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Prophylactic Gamma Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Prophylactic Gamma Globulin Sales by Country (2020-2025) & (K Units)
Table 32. Europe Prophylactic Gamma Globulin Sales by Country (2026-2031) & (K Units)
Table 33. Europe Prophylactic Gamma Globulin Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Prophylactic Gamma Globulin Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Prophylactic Gamma Globulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Prophylactic Gamma Globulin Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Prophylactic Gamma Globulin Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Prophylactic Gamma Globulin Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Prophylactic Gamma Globulin Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Prophylactic Gamma Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Prophylactic Gamma Globulin Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Prophylactic Gamma Globulin Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Prophylactic Gamma Globulin Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Prophylactic Gamma Globulin Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Prophylactic Gamma Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Prophylactic Gamma Globulin Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Prophylactic Gamma Globulin Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Prophylactic Gamma Globulin Sales (K Units) by Type (2020-2025)
Table 51. Global Prophylactic Gamma Globulin Sales (K Units) by Type (2026-2031)
Table 52. Global Prophylactic Gamma Globulin Sales Market Share by Type (2020-2025)
Table 53. Global Prophylactic Gamma Globulin Sales Market Share by Type (2026-2031)
Table 54. Global Prophylactic Gamma Globulin Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Prophylactic Gamma Globulin Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2020-2025)
Table 57. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2026-2031)
Table 58. Global Prophylactic Gamma Globulin Price (US$/Unit) by Type (2020-2025)
Table 59. Global Prophylactic Gamma Globulin Price (US$/Unit) by Type (2026-2031)
Table 60. Global Prophylactic Gamma Globulin Sales (K Units) by Application (2020-2025)
Table 61. Global Prophylactic Gamma Globulin Sales (K Units) by Application (2026-2031)
Table 62. Global Prophylactic Gamma Globulin Sales Market Share by Application (2020-2025)
Table 63. Global Prophylactic Gamma Globulin Sales Market Share by Application (2026-2031)
Table 64. Global Prophylactic Gamma Globulin Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Prophylactic Gamma Globulin Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2020-2025)
Table 67. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2026-2031)
Table 68. Global Prophylactic Gamma Globulin Price (US$/Unit) by Application (2020-2025)
Table 69. Global Prophylactic Gamma Globulin Price (US$/Unit) by Application (2026-2031)
Table 70. Baxter Company Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Baxter Prophylactic Gamma Globulin Product
Table 74. Baxter Recent Developments/Updates
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Grifols Prophylactic Gamma Globulin Product
Table 79. Grifols Recent Developments/Updates
Table 80. Octapharma Company Information
Table 81. Octapharma Description and Business Overview
Table 82. Octapharma Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Octapharma Prophylactic Gamma Globulin Product
Table 84. Octapharma Recent Developments/Updates
Table 85. Biotest Company Information
Table 86. Biotest Description and Business Overview
Table 87. Biotest Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Biotest Prophylactic Gamma Globulin Product
Table 89. Biotest Recent Developments/Updates
Table 90. Kedrion Biopharma Company Information
Table 91. Kedrion Biopharma Description and Business Overview
Table 92. Kedrion Biopharma Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Kedrion Biopharma Prophylactic Gamma Globulin Product
Table 94. Kedrion Biopharma Recent Developments/Updates
Table 95. Takeda Company Information
Table 96. Takeda Description and Business Overview
Table 97. Takeda Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Takeda Prophylactic Gamma Globulin Product
Table 99. Takeda Recent Developments/Updates
Table 100. ADMA Biologics Company Information
Table 101. ADMA Biologics Description and Business Overview
Table 102. ADMA Biologics Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. ADMA Biologics Prophylactic Gamma Globulin Product
Table 104. ADMA Biologics Recent Developments/Updates
Table 105. BPL Company Information
Table 106. BPL Description and Business Overview
Table 107. BPL Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. BPL Prophylactic Gamma Globulin Product
Table 109. BPL Recent Developments/Updates
Table 110. LFB Group Company Information
Table 111. LFB Group Description and Business Overview
Table 112. LFB Group Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. LFB Group Prophylactic Gamma Globulin Product
Table 114. LFB Group Recent Developments/Updates
Table 115. Hualan Biological Company Information
Table 116. Hualan Biological Description and Business Overview
Table 117. Hualan Biological Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Hualan Biological Prophylactic Gamma Globulin Product
Table 119. Hualan Biological Recent Developments/Updates
Table 120. Beijing Tiantan Biological Company Information
Table 121. Beijing Tiantan Biological Description and Business Overview
Table 122. Beijing Tiantan Biological Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Beijing Tiantan Biological Prophylactic Gamma Globulin Product
Table 124. Beijing Tiantan Biological Recent Developments/Updates
Table 125. Beijing Bohui Innovation Biotechnology Company Information
Table 126. Beijing Bohui Innovation Biotechnology Description and Business Overview
Table 127. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product
Table 129. Beijing Bohui Innovation Biotechnology Recent Developments/Updates
Table 130. Pacific Shuanglin Bio-pharmacy Company Information
Table 131. Pacific Shuanglin Bio-pharmacy Description and Business Overview
Table 132. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product
Table 134. Pacific Shuanglin Bio-pharmacy Recent Developments/Updates
Table 135. Shenzhen Weiguang Biological Company Information
Table 136. Shenzhen Weiguang Biological Description and Business Overview
Table 137. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product
Table 139. Shenzhen Weiguang Biological Recent Developments/Updates
Table 140. CBPO Company Information
Table 141. CBPO Description and Business Overview
Table 142. CBPO Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. CBPO Prophylactic Gamma Globulin Product
Table 144. CBPO Recent Developments/Updates
Table 145. CNBG Company Information
Table 146. CNBG Description and Business Overview
Table 147. CNBG Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. CNBG Prophylactic Gamma Globulin Product
Table 149. CNBG Recent Developments/Updates
Table 150. Shanghai RAAS Company Information
Table 151. Shanghai RAAS Description and Business Overview
Table 152. Shanghai RAAS Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Shanghai RAAS Prophylactic Gamma Globulin Product
Table 154. Shanghai RAAS Recent Developments/Updates
Table 155. Sichuan Yuanda Shuyang Company Information
Table 156. Sichuan Yuanda Shuyang Description and Business Overview
Table 157. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product
Table 159. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Prophylactic Gamma Globulin Distributors List
Table 163. Prophylactic Gamma Globulin Customers List
Table 164. Prophylactic Gamma Globulin Market Trends
Table 165. Prophylactic Gamma Globulin Market Drivers
Table 166. Prophylactic Gamma Globulin Market Challenges
Table 167. Prophylactic Gamma Globulin Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Prophylactic Gamma Globulin
Figure 2. Global Prophylactic Gamma Globulin Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prophylactic Gamma Globulin Market Share by Type: 2024 & 2031
Figure 4. IVIg Liquid Product Picture
Figure 5. IVIg Powder Product Picture
Figure 6. Global Prophylactic Gamma Globulin Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Prophylactic Gamma Globulin Market Share by Application: 2024 & 2031
Figure 8. Immunodeficiency
Figure 9. Autoimmune Disease
Figure 10. Acute Infection
Figure 11. Global Prophylactic Gamma Globulin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Prophylactic Gamma Globulin Market Size (2020-2031) & (US$ Million)
Figure 13. Global Prophylactic Gamma Globulin Sales (2020-2031) & (K Units)
Figure 14. Global Prophylactic Gamma Globulin Average Price (US$/Unit) & (2020-2031)
Figure 15. Prophylactic Gamma Globulin Report Years Considered
Figure 16. Prophylactic Gamma Globulin Sales Share by Manufacturers in 2024
Figure 17. Global Prophylactic Gamma Globulin Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Prophylactic Gamma Globulin Players: Market Share by Revenue in Prophylactic Gamma Globulin in 2024
Figure 19. Prophylactic Gamma Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Prophylactic Gamma Globulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Prophylactic Gamma Globulin Sales Market Share by Country (2020-2031)
Figure 22. North America Prophylactic Gamma Globulin Revenue Market Share by Country (2020-2031)
Figure 23. United States Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Prophylactic Gamma Globulin Sales Market Share by Country (2020-2031)
Figure 26. Europe Prophylactic Gamma Globulin Revenue Market Share by Country (2020-2031)
Figure 27. Germany Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Prophylactic Gamma Globulin Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Prophylactic Gamma Globulin Revenue Market Share by Region (2020-2031)
Figure 34. China Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Prophylactic Gamma Globulin Sales Market Share by Country (2020-2031)
Figure 42. Latin America Prophylactic Gamma Globulin Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Prophylactic Gamma Globulin Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Prophylactic Gamma Globulin Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Prophylactic Gamma Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Prophylactic Gamma Globulin by Type (2020-2031)
Figure 52. Global Revenue Market Share of Prophylactic Gamma Globulin by Type (2020-2031)
Figure 53. Global Prophylactic Gamma Globulin Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Prophylactic Gamma Globulin by Application (2020-2031)
Figure 55. Global Revenue Market Share of Prophylactic Gamma Globulin by Application (2020-2031)
Figure 56. Global Prophylactic Gamma Globulin Price (US$/Unit) by Application (2020-2031)
Figure 57. Prophylactic Gamma Globulin Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fatigue Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global Blast Impact Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global On-Line Analytical Processing (OLAP) Business Intelligence Consulting Services Market Research Report 2025
Jul 29, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232